Who owns ANI PHARMACEUTICALS INC?
- CUSIP Number: 00182cac7
Tip: Access positions for across all investors
Analyze quarterly positions in Ani Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ani Pharmaceuticals stock
Who bought or sold ANI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Camden Asset Management | 41M | $50B | -6% | Mar 2026 |
|
| Alberta Investment Management Corporation | 30M | $37M | 0% | Mar 2026 |
|
| Citadel Advisors | 25M | $31M | 67% | Mar 2026 |
|
| Empyrean Capital Partners | 24M | $29M | 12% | Mar 2026 |
|
| HBK Investments | 20M | $25M | -11% | Mar 2026 |
|
| Point72 Asset Management | 15M | $19M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 15M | $19M | 100% | Mar 2026 |
|
| Readystate Asset Management | 14M | $18M | 100% | Mar 2026 |
|
| BlackRock | 13M | $16M | 14% | Mar 2026 |
|
| Absolute Investment Advisers | 12M | $14M | 0% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 8.0M | $10M | 51% | Mar 2026 |
|
| Aristeia Capital | 8.0M | $9.9M | 100% | Mar 2026 |
|
| Leucadia National Corporation | 5.1M | $6.3M | -33% | Mar 2026 |
|
| Gabelli Funds | 5.1M | $6.4M | 0% | Dec 2025 |
|
| Susquehanna Advisors Group | 5.0M | $63k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 5.0M | $6.2M | 231% | Mar 2026 |
|
| FMR | 2.6M | $3.2M | 0% | Dec 2025 |
|
| Citigroup | 1.5M | $1.9M | 100% | Mar 2026 |
|
| Bank of New York Mellon | 1.0M | $1.2M | 18% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 649k | $804k | -58% | Mar 2026 |
|
| Jane Street | 380k | $469k | 100% | Mar 2026 |
|
| Lazard Asset Management | 351k | $4.4k | -63% | Mar 2026 |
|
| Morgan Stanley | 337k | $417k | -60% | Mar 2026 |
|
| Boussard & Gavaudan Investment Management | 19k | $24M | 85% | Dec 2025 |
|
| Alken Asset Management | 1.3k | $1.6M | 100% | Mar 2026 |
|
Who sold out of Ani Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2025 | 71M | $100M |
| Millennium Management | Dec 2025 | 24M | $30M |
| Brevan Howard Capital Management | Dec 2025 | 15M | $19M |
| Context Capital Management | Dec 2025 | 10M | $13M |
| Jpmorgan Chase & Co | Sep 2025 | 9.3M | $13M |
| Picton Mahoney Asset Management | Dec 2025 | 4.0M | $5.0M |
| Ares Systematic Credit | Dec 2025 | 100k | $127k |
| Calamos Advisors | Dec 2025 | 39k | $49k |